At a glance
ClinicalIndex Comparison RecordN/ACompleted· 110 enrolled
Drug / intervention
ROIC interbody cage with VerteBRIDGE platingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-Label Clinical Study of the Safety and Efficacy of the ROI-C Anterior Cervical Interbody Fusion Device Using the VerteBRIDGE Plating System
In Brief
An observational study evaluating ROIC interbody cage with VerteBRIDGE plating for Degenerative Disc Disease. Completed, enrolled 110 participants across 7 sites.
Detailed Summary
The purpose of this combined retrospective and prospective clinical study is to examine the clinical outcomes of the ROI-C® anterior cervical interbody fusion device with VerteBRIDGE® plating to treat single level degenerative disc disease between C2 and T1 in the short term, with a focus on fusion rates.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDegenerative Disc Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartSep 2013
First PostedApr 2014
Primary CompletionApr 2015
Study CompletionJun 2015
TodayJul 2026
First PostedApr 4, 2014
Enrollment StartSep 1, 2013
Primary CompletionApr 1, 2015
Study CompletionJun 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 12.2 years ago
Interventions
ROIC interbody cage with VerteBRIDGE platingdevice